Compare Eterindo Wahanatama Tbk (ETWA) vs UBC Medical Indonesia Tbk. (LABS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Eterindo Wahanatama Tbk vs UBC Medical Indonesia Tbk. — how do they compare? Eterindo Wahanatama Tbk trades at Rp70 (market cap 326.81B), while UBC Medical Indonesia Tbk. trades at Rp174 (market cap 691.25B, 635.5K 24h volume). The key difference: UBC Medical Indonesia Tbk. is far larger — about 2.1× Eterindo Wahanatama Tbk's market cap. Which is the better fit depends on your goals.
| ETWA | LABS | |
|---|---|---|
Market Cap | 326.81B | 691.25B |
Volume | — | 635.5K |
Lot | — | 6.36K |
Turnover | — | 110.15M |
Average Price | — | 173.33 |
Value | — | 110.15M |
Indicative Equilibrium Price | — | 174 |
Indicative Equilibrium Volume | — | 50 |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Eterindo Wahanatama Tbk
PT Eterindo Wahanatama Tbk or Eterindo is the parent company to midstream specialty chemical companies, interrelated by ownership and through both vertical and horizontal integration. Eterindo has established itself as one of the largest producers of specialty in South East Asia. The products are used as raw material in the production of paints, coatings, adhesives and similar consumer product realm. The breadth of its range gives Eterindo a distinct edge over its competitors.Presently, Eterindo is among the largest producers of plasticizers, an important raw material for producing cables, footwear, tyres and other basic consumer goods, near to one daily usage in life. Modern production facilities, state of the art technology and a highly trained and dedicated labour force means Eterindo companies will continue to offer high quality at competitive prices, to customers at home and overseas. In recognition of its technical achievement, Eterindo has been awarded ISO 9002 certification. Strategic partnership have been formed with multinationals, including Mitsui & Co. Ltd. Of Japan, Kyowa Hakko Kogyo Co. Ltd., Mitsui Bussan Solvent & Coating Co., Ltd., Daewoo Group of Korea and state owned company PT Petrokimia Gresik.
Read more on ETWA →About UBC Medical Indonesia Tbk.
PT UBC Medical Indonesia (the Company) was established under the framework of Law of the Republic of Indonesia No. 20 year 1994 concerning the Foreign Capital Investment, as amended by Law No. 25 year 2007 concerning the Capital Investment based on Notarial Deed No. 01 dated 4 June 2014 of Novita Puspitarini, S.H., Notary in Jakarta. The Company started its commercial activities in October 2014. The parent entity as well as the ultimate parent entity of the Company is PT Optel Investama Mulia.
Read more on LABS →
